PharMerica Corp (PMC)

HEALTH CARE: HEALTH CARE SERVICES
SIC: RETAIL-DRUG STORES AND PROPRIETARY STORES
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1901 CAMPUS PLACE LOUISVILLE, KY 40299

PharMerica Corporation operates as an institutional pharmacy services provider, which provides pharmacy solutions and customer service to institutional customers and patients in long-term care settings in the United States. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. Its customers primarily include institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. As of July 31, 2007, the company operated approximately 120 institutional pharmacies in 40 states. It also provides pharmacy management services to 81 hospitals. In addition, PharMerica provides various supplemental healthcare services, such as infusion therapy services, and formulary management and other pharmacy consulting services.

Are you looking for this stock instead?

View SEC Filings from PMC instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PMC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PMC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OAKLEY ROBERT A

  • Director
No longer subject to file 2017-12-07 0

COLLINS FRANK E

  • Director
No longer subject to file 2017-12-07 0

DAHL W ROBERT JR

  • Director
No longer subject to file 2017-12-07 0

DORR MARJORIE W

  • Director
No longer subject to file 2017-12-07 0

TOMASSETTI BERARD SVP AND CAO

  • Officer
No longer subject to file 2017-12-07 0

CANERIS THOMAS A SVP, GC AND SECRETARY

  • Officer
No longer subject to file 2017-12-07 0

MCKAY ROBERT A SVP PURCHASING,TRADE RELATIONS

  • Officer
No longer subject to file 2017-12-07 0

MEYERS GEOFFREY G

  • Director
No longer subject to file 2017-12-07 0

VISHNUBHATLA SURESH EVP, LTC OPERATIONS

  • Officer
No longer subject to file 2017-12-07 0

LEPORE PATRICK G

  • Director
No longer subject to file 2017-12-07 0

DRIES ROBERT E. CFO

  • Officer
No longer subject to file 2017-12-07 0

WEISHAR GREGORY S CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2017-11-07 0

FROESEL DAVID W JR EXECUTIVE VP, CFO & TREASURER

  • Officer
82,371 2016-08-01 0

GERRITY THOMAS P

  • Director
53,312 2016-06-17 0

MAC MAHON THOMAS P

  • Director
58,606 2016-06-17 0

LINDEMOEN MARK SVP SALES AND CLIENT SERVICES

  • Officer
25,036 2016-03-21 0

GLYNN JAMES D PRESIDENT, AMERITA, INC.

  • Officer
0 2014-04-30 0

HERNANDEZ ANTHONY SVP OF HUMAN RESOURCES

  • Officer
44,969 2013-11-15 0

CULOTTA MICHAEL J EVP AND CFO

  • Officer
183,369 2013-03-25 0

MONAST WILLIAM E EVP

  • Officer
57,010 2012-06-15 0

MENDELSON DANIEL NEWMAN

  • Director
17,629 2010-05-26 0

KERNAGHAN JOHN CHIEF INFORMATION OFFICER

  • Officer
25,000 2008-07-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments